These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1596310)

  • 1. Probing angiotensin receptors.
    Seyer R; Richoux JP; Aumelas A
    Int J Biochem; 1992 Mar; 24(3):369-77. PubMed ID: 1596310
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural comparison between type I and type II antagonists: possible implications in the drug design of AT1 antagonists.
    Roumelioti P; Tselios T; Alexopoulos K; Mavromoustakos T; Kolocouris A; Moore GJ; Matsoukas JM
    Bioorg Med Chem Lett; 2000 Apr; 10(8):755-8. PubMed ID: 10782679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-binding studies of the adrenal AT4 receptor: analysis of position two- and three-modified angiotensin IV analogs.
    Krishnan R; Hanesworth JM; Wright JW; Harding JW
    Peptides; 1999; 20(8):915-20. PubMed ID: 10503768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoprobe peptides to map the interactions of angiotensin II with its receptor AT1.
    Fillion D; Guillemette G; Leduc R; Escher E
    Adv Exp Med Biol; 2009; 611():329-30. PubMed ID: 19400214
    [No Abstract]   [Full Text] [Related]  

  • 5. Bicyclic tripeptide mimetics with reverse turn inducing properties.
    Johannesson P; Lindeberg G; Tong W; Gogoll A; Karlén A; Hallberg A
    J Med Chem; 1999 Feb; 42(4):601-8. PubMed ID: 10052967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple binding modes for the receptor-bound conformations of cyclic AII agonists.
    Plucinska K; Kataoka T; Yodo M; Cody WL; He JX; Humblet C; Lu GH; Lunney E; Major TC; Panek RL
    J Med Chem; 1993 Jun; 36(13):1902-13. PubMed ID: 8515427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II receptor pharmacology.
    Griendling KK; Lassègue B; Murphy TJ; Alexander RW
    Adv Pharmacol; 1994; 28():269-306. PubMed ID: 8080819
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis of a biotinylated, iodinatable, and photoactivatable probe for angiotensin receptors.
    Seyer R; Aumelas A; Tence M; Marie J; Bonnafous JC; Jard S; Castro B
    Int J Pept Protein Res; 1989 Sep; 34(3):235-45. PubMed ID: 2599762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8.
    Hsieh KH; LaHann TR; Speth RC
    J Med Chem; 1989 Apr; 32(4):898-903. PubMed ID: 2704034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photolabelling implicates an amino acid in the second transmembrane domain of the rat AT1A receptor in agonist binding.
    Bajaj BP; Balmforth AJ; Ball SG
    Biochem Soc Trans; 1995 Feb; 23(1):86S. PubMed ID: 7758806
    [No Abstract]   [Full Text] [Related]  

  • 11. New probes for angiotensin II receptors. Synthesis, radioiodination and biological properties of biotinylated and haptenated angiotensin derivatives.
    Bonnafous JC; Tence M; Seyer R; Marie J; Aumelas A; Jard S
    Biochem J; 1988 May; 251(3):873-80. PubMed ID: 3415650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, receptor binding affinities and conformational properties of cyclic methylenedithioether analogues of angiotensin II.
    Lindman S; Lindeberg G; Gogoll A; Nyberg F; Karlén A; Hallberg A
    Bioorg Med Chem; 2001 Mar; 9(3):763-72. PubMed ID: 11310611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II analogues encompassing 5,9- and 5,10-fused thiazabicycloalkane tripeptide mimetics.
    Johannesson P; Lindeberg G; Tong W; Gogoll A; Synnergren B; Nyberg F; Karlén A; Hallberg A
    J Med Chem; 1999 Nov; 42(22):4524-37. PubMed ID: 10579816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AT4 receptor binding characteristics: D-amino acid- and glycine-substituted peptides.
    Sardinia MF; Hanesworth JM; Krebs LT; Harding JW
    Peptides; 1993; 14(5):949-54. PubMed ID: 8284271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of the structure and molecular functions of angiotensin II and vasopressin receptors].
    Clauser E
    C R Seances Soc Biol Fil; 1995; 189(2):179-90. PubMed ID: 8590217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II is bound to both receptors AT1 and AT2, parallel to the transmembrane domains and in an extended form.
    Deraët M; Rihakova L; Boucard A; Pèrodin J; Sauvé S; Mathieu AP; Guillemette G; Leduc R; Lavigne P; Escher E
    Can J Physiol Pharmacol; 2002 May; 80(5):418-25. PubMed ID: 12056548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Angiotensin receptors].
    Sirakova I; Sirakov L
    Eksp Med Morfol; 1981; 20(3):125-9. PubMed ID: 6273115
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin II receptors. Structural and functional considerations.
    Speth RC; Thompson SM; Johns SJ
    Adv Exp Med Biol; 1995; 377():169-92. PubMed ID: 7484422
    [No Abstract]   [Full Text] [Related]  

  • 19. Vinyl sulfide cyclized analogues of angiotensin II with high affinity and full agonist activity at the AT(1) receptor.
    Johannesson P; Lindeberg G; Johansson A; Nikiforovich GV; Gogoll A; Synnergren B; Le Grèves M; Nyberg F; Karlén A; Hallberg A
    J Med Chem; 2002 Apr; 45(9):1767-77. PubMed ID: 11960488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational restriction of angiotensin II: cyclic analogues having high potency.
    Spear KL; Brown MS; Reinhard EJ; McMahon EG; Olins GM; Palomo MA; Patton DR
    J Med Chem; 1990 Jul; 33(7):1935-40. PubMed ID: 2362273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.